Work

AXL in metastatic ovarian cancer tumors is a targetable biomarker associated with chemoresistance and poor prognosis

Year: 2019

Type: article

Study design: Observational Study

Source: Gynecologic Oncology

DOI: 10.1016/j.ygyno.2019.04.188

Authors: M.M. Mullen, J.M. Quinn, M. Greenwade, G. Opara, H. Beck-Noia, I.S. Hagemann, A.R. Hagemann, L.M. Kuroki, C.K. McCourt, P.H. Thaker, M.A. Powell, D.G. Mutch, K.C. Fuh

Institutions: Washington University in St. Louis, University of Oklahoma Health Sciences Center, Brown University

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2955720954

FWCI:

Cites:

Cited by:

Related to: 10